Overview

Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the efficacy in patients with cystic fibrosis and pancreatic insufficiency following treatment with BSSL
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Swedish Orphan Biovitrum
Criteria
Inclusion Criteria:

- Patients with cystic fibrosis and pancreatic insufficiency who are able to refrain
from their ongoing pancreatic enzyme treatment for a period of 7 days and are able to
produce stools >= 5 times per week